Skip to search formSkip to main contentSkip to account menu

B-Cell Lymphomas

Known as: lymphoma b-cell, cell b lymphoma, b cell lymphomas 
A type of cancer that forms in B cells (a type of immune system cell). B-cell lymphomas usually occur in adults and may be either indolent (slow… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Background In a phase 1 trial, axicabtagene ciloleucel (axi‐cel), an autologous anti‐CD19 chimeric antigen receptor (CAR) T‐cell… 
Highly Cited
2008
Highly Cited
2008
BACKGROUND The addition of rituximab to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone… 
Review
2005
Review
2005
Primary cutaneous lymphomas are currently classified by the European Organization for Research and Treatment of Cancer (EORTC… 
Highly Cited
2005
Highly Cited
2005
We show that the microRNA miR-155 can be processed from sequences present in BIC RNA, a spliced and polyadenylated but non… 
Highly Cited
2004
Highly Cited
2004
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important subgroups with germinal center B-cell-like… 
Highly Cited
2002
Highly Cited
2002
Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND The survival of patients with diffuse large-B-cell lymphoma after chemotherapy is influenced by molecular features of… 
Highly Cited
2002
Highly Cited
2002
Diffuse large B-cell lymphoma (DLBCL), the most common lymphoid malignancy in adults, is curable in less than 50% of patients… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… 
Highly Cited
2000
Highly Cited
2000
Diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphoma, is clinically heterogeneous: 40% of…